What is CVE-2023-36351?

CVE-2023-36351 is a high-severity vulnerability in Viatomtech Vihealth. CVSS score: 7.8/10. Published 2023-08-01.

How severe is CVE-2023-36351?

High severity. CVSS v3 base score is 7.8 out of 10.

Is CVE-2023-36351 known to be exploited?

1 public proof-of-concept repositories are indexed. Not currently listed in the CISA KEV catalog.

Vulnerability in Viatomtech Vihealth

CVE-2023-36351

An issue in Viatom Health ViHealth for Android v.2.74.58 and before allows a remote attacker to execute arbitrary code via the com.viatom.baselib.mvvm.webWebViewActivity component.

EPSS: 0.009 (55.9th percentile) — read the EPSS interpretation.

CVSS v3 metric

CVSS v3 base score 7.8 (High). Vector: CVSS:3.1/AV:L/AC:L/PR:N/UI:R/S:U/C:H/I:H/A:H.

Affected products

Viatomtech Vihealth
N/a — versions n/a

Public proof-of-concept exploits

actuator/cve

References

cve@mitre.org (Exploit, Third Party Advisory)
cve@mitre.org (Third Party Advisory)

Frequently asked questions

What is CVE-2023-36351?: CVE-2023-36351 is a high-severity vulnerability in Viatomtech Vihealth. CVSS score: 7.8/10. Published 2023-08-01.
How severe is CVE-2023-36351?: High severity. CVSS v3 base score is 7.8 out of 10.
Is CVE-2023-36351 known to be exploited?: 1 public proof-of-concept repositories are indexed. Not currently listed in the CISA KEV catalog.